Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 3 | 2025 | 23 | 1.800 |
Why?
|
| Dysentery, Bacillary | 2 | 2024 | 2 | 1.680 |
Why?
|
| Vaccines | 3 | 2024 | 10 | 1.200 |
Why?
|
| Staphylococcal Vaccines | 4 | 2024 | 4 | 1.110 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 2 | 1.080 |
Why?
|
| Staphylococcus aureus | 7 | 2024 | 11 | 1.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2024 | 14 | 1.010 |
Why?
|
| Staphylococcal Infections | 6 | 2024 | 16 | 0.970 |
Why?
|
| beta-Lactamases | 2 | 2024 | 3 | 0.940 |
Why?
|
| Aspergillus fumigatus | 1 | 2025 | 1 | 0.920 |
Why?
|
| Drug Resistance, Fungal | 1 | 2025 | 1 | 0.920 |
Why?
|
| Antifungal Agents | 1 | 2025 | 9 | 0.920 |
Why?
|
| Triazoles | 1 | 2025 | 12 | 0.920 |
Why?
|
| Shigella sonnei | 1 | 2024 | 1 | 0.890 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2024 | 4 | 0.890 |
Why?
|
| Gene Library | 1 | 2024 | 2 | 0.860 |
Why?
|
| Shigella | 1 | 2023 | 1 | 0.800 |
Why?
|
| Humans | 17 | 2025 | 6794 | 0.760 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2025 | 10 | 0.700 |
Why?
|
| Mice | 8 | 2024 | 746 | 0.450 |
Why?
|
| Anti-Bacterial Agents | 3 | 2024 | 73 | 0.450 |
Why?
|
| Interleukin-10 | 2 | 2024 | 10 | 0.440 |
Why?
|
| Animals | 9 | 2024 | 1875 | 0.420 |
Why?
|
| Clinical Trials as Topic | 2 | 2024 | 54 | 0.400 |
Why?
|
| Los Angeles | 2 | 2024 | 321 | 0.390 |
Why?
|
| Mutation | 2 | 2025 | 97 | 0.270 |
Why?
|
| Antibodies, Bacterial | 2 | 2024 | 5 | 0.260 |
Why?
|
| Aspergillosis | 1 | 2025 | 1 | 0.230 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2025 | 3 | 0.230 |
Why?
|
| Fungal Proteins | 1 | 2025 | 2 | 0.230 |
Why?
|
| Genotype | 1 | 2025 | 28 | 0.230 |
Why?
|
| Nitriles | 1 | 2025 | 13 | 0.230 |
Why?
|
| Pyridines | 1 | 2025 | 24 | 0.230 |
Why?
|
| Interleukin-17 | 1 | 2024 | 2 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 38 | 0.220 |
Why?
|
| Palate, Hard | 1 | 2024 | 1 | 0.220 |
Why?
|
| Genome, Bacterial | 1 | 2024 | 4 | 0.220 |
Why?
|
| Fungi | 1 | 2024 | 4 | 0.210 |
Why?
|
| Bacteria | 1 | 2024 | 9 | 0.210 |
Why?
|
| Workflow | 1 | 2024 | 7 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 18 | 0.210 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2023 | 2 | 0.210 |
Why?
|
| Immunization | 1 | 2024 | 19 | 0.210 |
Why?
|
| Acne Vulgaris | 1 | 2023 | 4 | 0.210 |
Why?
|
| Homosexuality, Male | 1 | 2024 | 83 | 0.210 |
Why?
|
| Aeromonas | 1 | 2023 | 1 | 0.210 |
Why?
|
| United States Food and Drug Administration | 1 | 2023 | 7 | 0.210 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2023 | 7 | 0.200 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 12 | 0.200 |
Why?
|
| Cross Infection | 1 | 2023 | 12 | 0.200 |
Why?
|
| Bacterial Proteins | 1 | 2023 | 10 | 0.200 |
Why?
|
| Academic Medical Centers | 1 | 2023 | 23 | 0.200 |
Why?
|
| Cytomegalovirus | 1 | 2023 | 7 | 0.200 |
Why?
|
| Shigella flexneri | 1 | 2023 | 1 | 0.200 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2023 | 2 | 0.200 |
Why?
|
| Cytomegalovirus Infections | 1 | 2023 | 31 | 0.200 |
Why?
|
| Coinfection | 1 | 2022 | 4 | 0.190 |
Why?
|
| Cation Transport Proteins | 1 | 2022 | 1 | 0.190 |
Why?
|
| Mesentery | 1 | 2020 | 1 | 0.170 |
Why?
|
| Bacterial Translocation | 1 | 2020 | 2 | 0.170 |
Why?
|
| Bacteremia | 1 | 2020 | 8 | 0.160 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 18 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 26 | 0.160 |
Why?
|
| Male | 3 | 2023 | 3671 | 0.160 |
Why?
|
| Adipose Tissue | 1 | 2020 | 69 | 0.160 |
Why?
|
| United States | 1 | 2023 | 1019 | 0.150 |
Why?
|
| Vaccination | 3 | 2024 | 49 | 0.150 |
Why?
|
| Female | 5 | 2024 | 4060 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 258 | 0.130 |
Why?
|
| Biomarkers | 2 | 2020 | 214 | 0.080 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2024 | 1 | 0.060 |
Why?
|
| Immune Evasion | 1 | 2024 | 1 | 0.060 |
Why?
|
| Sialyltransferases | 1 | 2024 | 2 | 0.060 |
Why?
|
| Glycosylation | 1 | 2024 | 2 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2024 | 9 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2024 | 23 | 0.060 |
Why?
|
| STAT3 Transcription Factor | 1 | 2024 | 16 | 0.060 |
Why?
|
| Toothache | 1 | 2024 | 1 | 0.050 |
Why?
|
| Oral Ulcer | 1 | 2024 | 3 | 0.050 |
Why?
|
| Propionibacterium acnes | 1 | 2023 | 3 | 0.050 |
Why?
|
| Skin | 1 | 2023 | 10 | 0.050 |
Why?
|
| Amino Acids | 1 | 2023 | 15 | 0.050 |
Why?
|
| Sanitary Engineering | 1 | 2023 | 1 | 0.050 |
Why?
|
| Aeromonas hydrophila | 1 | 2023 | 1 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2023 | 9 | 0.050 |
Why?
|
| Drug Resistance, Viral | 1 | 2023 | 1 | 0.050 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2023 | 2 | 0.050 |
Why?
|
| Gene Amplification | 1 | 2023 | 3 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2023 | 24 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2023 | 53 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2022 | 3 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 43 | 0.050 |
Why?
|
| Phagocytosis | 1 | 2022 | 18 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 3 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2020 | 3 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2020 | 2 | 0.040 |
Why?
|
| Metagenome | 1 | 2020 | 4 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 7 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2020 | 5 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 3 | 0.040 |
Why?
|
| Ileum | 1 | 2020 | 7 | 0.040 |
Why?
|
| Biodiversity | 1 | 2020 | 6 | 0.040 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 5 | 0.040 |
Why?
|
| Metabolomics | 1 | 2020 | 4 | 0.040 |
Why?
|
| Coagulase | 1 | 2020 | 1 | 0.040 |
Why?
|
| beta-Glucans | 1 | 2020 | 1 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2020 | 3 | 0.040 |
Why?
|
| Th17 Cells | 1 | 2020 | 4 | 0.040 |
Why?
|
| Proteomics | 1 | 2020 | 9 | 0.040 |
Why?
|
| Stem Cells | 1 | 2020 | 19 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 41 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 91 | 0.040 |
Why?
|
| Macrophages | 1 | 2020 | 40 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 120 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2020 | 234 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 220 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 231 | 0.040 |
Why?
|
| Risk Factors | 1 | 2020 | 767 | 0.030 |
Why?
|
| Adult | 1 | 2022 | 2113 | 0.030 |
Why?
|
| Middle Aged | 1 | 2020 | 2108 | 0.030 |
Why?
|